| 1 |
35123623 | [Effect of Celastrol Based on IRAK4/ERK/p38 Signaling Pathway on Proliferation and Apoptosis of Multiple Myeloma Cells]. | 2022 Feb |
1 |
| 2 |
34571936 | Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation. | 2021 Sep 2 |
1 |
| 3 |
32298237 | Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis. | 2020 Apr 16 |
1 |
| 4 |
29057477 | The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs. | 2018 May |
2 |
| 5 |
25530422 | The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer. | 2015 Aug 1 |
1 |
| 6 |
26059188 | Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence. | 2015 Oct 1 |
2 |
| 7 |
24104394 | MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma. | 2014 Apr |
1 |
| 8 |
25375375 | Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation. | 2014 Nov 6 |
3 |
| 9 |
22006557 | Involvement of mitogen-activated protein kinase in signal transducer and activator of transcription-1 mediated differentiation induced by bortezomib in acute myeloid leukemia cells. | 2013 Jan |
2 |
| 10 |
22313636 | Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitor. | 2012 Apr |
4 |
| 11 |
22848091 | PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells. | 2012 Oct |
3 |
| 12 |
23257432 | [Mechanism of apoptosis synergistically induced by bortezomib combined with cytarabine in U937 cell line]. | 2012 Dec |
1 |
| 13 |
21729547 | [Effect of different concentrations of bortezomib on the expression of ERK, JNK and P38 in daunorubicin-resistant K562 cells]. | 2011 Jun |
6 |
| 14 |
21176351 | [Effect of bortezomib on MAPK signaling pathway of K562/DNR cells]. | 2010 Dec |
4 |
| 15 |
18445700 | Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. | 2008 Jun |
1 |
| 16 |
19383353 | Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. | 2008 Dec |
1 |
| 17 |
14627979 | Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma. | 2003 Nov 20 |
1 |